The Place of Sulfonylureas in Guidelines: Why Are There Differences?

por Amod, Aslam
Publicado 2020

The Role of Real-World Evidence in Treatment Decision-Making, Regulatory Assessment, and Understanding the Perspectives of People with Type 2 Diabetes: Examples with Gliclazide MR

por Khunti, Kamlesh, Almalki, Mussa, Chan, Juliana C. N., Amod, Aslam
Publicado 2023

Effect of Rimonabant on Glycemic Control in Insulin-Treated Type 2 Diabetes: The ARPEGGIO Trial

por Hollander, Priscilla A., Amod, Aslam, Litwak, León E., Chaudhari, Umesh
Publicado 2010

Role of Gliclazide MR in the Management of Type 2 Diabetes: Report of a Symposium on Real-World Evidence and New Perspectives

por Khunti, Kamlesh, Hassanein, Mohamed, Lee, Moon-Kyu, Mohan, Viswanathan, Amod, Aslam
Publicado 2020

Introduction: Real-World Evidence in Type 2 Diabetes

por Hassanein, Mohamed, Amod, Aslam, Khunti, Kamlesh, Lee, Moon-Kyu, Mohan, Viswanathan
Publicado 2020

Abstract 138: Efficacy of oral semaglutide according to race: An exploratory subgroup analysis of the PIONEER trial program

por Srivastava, Kunal, Desouza, Cyrus, Amod, Aslam, Kallenbach, Klaus, Lin, Peter J, Nielsen, Morten Abildlund
Publicado 2022

Management of Diabetes and Hypertension within the Gulf Region: Updates on Treatment Practices and Therapies

por Hassanein, Mohamed, Akbar, Mousa A. J., Al-shamiri, Mostafa, Amir, Ashraf, Amod, Aslam, Chudleigh, Richard, Elhadd, Tarik, Heshmat, Hussien, Jibani, Mahdi, Al Saleh, Yousef M.
Publicado 2022

Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP‐1RA treatment: A subgroup analysis from the FIDELIO‐DKD trial

por Rossing, Peter, Agarwal, Rajiv, Anker, Stefan D., Filippatos, Gerasimos, Pitt, Bertram, Ruilope, Luis M., Amod, Aslam, Marre, Michel, Joseph, Amer, Lage, Andrea, Scott, Charlie, Bakris, George L.
Publicado 2021

Glomerular Filtration Rate and Associated Risks of Cardiovascular Events, Mortality, and Severe Hypoglycemia in Patients with Type 2 Diabetes: Secondary Analysis (DEVOTE 11)

por Amod, Aslam, Buse, John B., McGuire, Darren K., Pieber, Thomas R., Pop-Busui, Rodica, Pratley, Richard E., Zinman, Bernard, Hansen, Marco Bo, Jia, Ting, Mark, Thomas, Poulter, Neil R.
Publicado 2019

Risk factors for kidney disorders in patients with type 2 diabetes at high cardiovascular risk: An exploratory analysis (DEVOTE 12)

por Amod, Aslam, Buse, John B, McGuire, Darren K, Pieber, Thomas R, Pop-Busui, Rodica, Pratley, Richard E, Zinman, Bernard, Hansen, Marco Bo, Jia, Ting, Mark, Thomas, Poulter, Neil R
Publicado 2020

A Practitioner’s Toolkit for Insulin Motivation in Adults with Type 1 and Type 2 Diabetes Mellitus: Evidence-Based Recommendations from an International Expert Panel

por Kalra, Sanjay, Bajaj, Sarita, Sharma, Surendra Kumar, Priya, Gagan, Baruah, Manash P., Sanyal, Debmalya, Das, Sambit, Chaudhury, Tirthankar, Gangopadhyay, Kalyan Kumar, Das, Ashok Kumar, Sethi, Bipin, Ayyar, Vageesh, Shaikh, Shehla, Shah, Parag, Jindal, Sushil, Deshmukh, Vaishali, Dave, Joel, Amod, Aslam, Joshi, Ansumali, Pokharel, Sunil, Pathan, Faruque, Afsana, Faria, Prasad, Indrajit, Murad, Moosa, Soelistijo, Soebagijo Adi, Purwoto, Johanes, Hussein, Zanariah, Horn, Lee Chung, Sahay, Rakesh, Somasundaram, Noel, Antonypillai, Charles, Sumanathilaka, Manilka, Bulugahapitiya, Uditha
Publicado 2020